Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
10.35
+0.45 (4.55%)
At close: May 9, 2025, 4:00 PM
10.35
0.00 (0.00%)
After-hours: May 9, 2025, 4:00 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $202.15 million as of May 9, 2025.
Market Cap
202.15M
Enterprise Value
193.51M
1-Year Change
n/a
Ranking
Category
Stock Price
10.35
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $202.15M, an increase of 32.88%. That is a compound annual growth rate of 47.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 202.15M | 30.03% |
| Dec 31, 2024 | 155.47M | 2.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |